Primo Nutraceuticals Inc.
BUGVF
OTC PK
04/30/2020 | 01/31/2020 | 10/31/2019 | 07/31/2019 | 04/30/2019 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 7.20K | 4.50K | 30.70K | 30.90K | 70.60K |
Total Receivables | 15.30K | 18.80K | 18.80K | 12.80K | 88.10K |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | -- | -- | -- | 11.40K | 33.50K |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | -- | -- | -- | -- |
Total Current Assets | 22.50K | 23.30K | 49.50K | 55.10K | 192.20K |
|
|||||
Total Current Assets | 22.50K | 23.30K | 49.50K | 55.10K | 192.20K |
Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | 1.69M | 1.91M | 1.96M | 1.83M | 1.87M |
Total Assets | 2.30M | 2.55M | 2.63M | 1.89M | 2.07M |
|
|||||
Total Accounts Payable | 159.70K | 147.10K | 242.20K | 233.20K | 113.50K |
Total Accrued Expenses | 221.30K | 83.90K | 84.40K | 365.10K | 97.70K |
Short-term Debt | 335.50K | 336.30K | 306.40K | 453.90K | 281.60K |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Liabilities | 1.18M | 1.25M | 1.25M | 1.25M | 1.25M |
Total Other Current Liabilities | 1.18M | 1.25M | 1.25M | 1.25M | 1.25M |
Total Current Liabilities | 1.90M | 1.82M | 1.89M | 2.30M | 1.74M |
|
|||||
Total Current Liabilities | 1.90M | 1.82M | 1.89M | 2.30M | 1.74M |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | 335.50K | 336.30K | 306.40K | 453.90K | 281.60K |
Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -- | -- | -- | -- | -- |
Total Liabilities | 1.90M | 1.82M | 1.89M | 2.30M | 1.74M |
|
|||||
Common Stock & APIC | 5.55M | 5.68M | 5.65M | 4.11M | 2.10M |
Retained Earnings | -5.20M | -5.01M | -4.97M | -4.59M | -2.36M |
Treasury Stock & Other | 59.40K | 62.30K | 62.70K | 62.70K | 591.10K |
Total Common Equity | 404.20K | 735.30K | 741.90K | -413.80K | 324.20K |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | 404.20K | 735.30K | 741.90K | -413.80K | 324.20K |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | 404.20K | 735.30K | 741.90K | -413.80K | 324.20K |
|